BG

Bellevue Group Portfolio holdings

AUM $4.54B
1-Year Est. Return 22.5%
This Quarter Est. Return
1 Year Est. Return
+22.5%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$6.21B
AUM Growth
-$804M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
166
New
Increased
Reduced
Closed

Top Buys

1
+$31.1M
2
+$24.2M
3
+$21.5M
4
HUM icon
Humana
HUM
+$20.8M
5
APLS icon
Apellis Pharmaceuticals
APLS
+$10.5M

Top Sells

1
+$60.3M
2
+$56.9M
3
+$32.8M
4
CRL icon
Charles River Laboratories
CRL
+$16.7M
5
TMO icon
Thermo Fisher Scientific
TMO
+$15M

Sector Composition

1 Healthcare 99.13%
2 Industrials 0.77%
3 Energy 0.04%
4 Communication Services 0.01%
5 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$448M 7.22%
911,530
-11,754
2
$419M 6.75%
9,233,700
-146,600
3
$349M 5.62%
1,002,735
-94,431
4
$291M 4.68%
2,583,550
-29,250
5
$242M 3.9%
828,999
-13,225
6
$165M 2.66%
3,170,250
-31,550
7
$158M 2.55%
894,345
-5,305
8
$154M 2.49%
1,495,325
-29,734
9
$151M 2.44%
1,560,968
-85,533
10
$144M 2.32%
2,491,450
-149,315
11
$140M 2.25%
2,646,295
-15,157
12
$131M 2.11%
4,721,500
-24,500
13
$130M 2.1%
258,205
+48,078
14
$130M 2.09%
475,613
-1,333
15
$126M 2.04%
2,252,851
+29,433
16
$100M 1.61%
3,677,115
+228,793
17
$99.3M 1.6%
4,013,500
18
$82.7M 1.33%
170,046
+42,673
19
$79.9M 1.29%
3,162,735
-138,176
20
$78.7M 1.27%
304,230
-33,493
21
$76.4M 1.23%
1,119,819
+113,047
22
$75.7M 1.22%
173,887
+71,434
23
$73.9M 1.19%
2,284,293
-3,330
24
$72.3M 1.16%
3,513,351
+398,976
25
$71M 1.14%
1,025,457
-12,635
1
2 3 4 5